The overall goal of this project is to demonstrate that the newly FDA-approved Airwave Oscillometry System (tremoFlo c-100, Thorasys) can be used to reliably and easily obtain lung function measurements in ECHO cohorts and that these oscillometry measures of respiratory resistance and compliance are important outcomes in relating pre-, peri-, and postnatal exposures to respiratory health throughout childhood.
ECHO Coordinating Center: Opportunities and Infrastructure Fund Component
Investigator: Ferrara, Assiamira
Funder: National Institutes of Health, Office of the Director
